Domov › Rakovina obličiek (renálny bunkový karcinóm) › Wisconsin

Klinické štúdie Rakovina obličiek (renálny bunkový karcinóm) v štáte Wisconsin

12 štúdií pre Rakovina obličiek (renálny bunkový karcinóm) hľadá účastníkov v zariadeniach v štáte Wisconsin.

Mestá v štáte Wisconsin

Oficiálny text štúdie (anglicky)

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

University of Wisconsin - Carbone Cancer Center, Madison

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
a 50 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #33, Milwaukee

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Medical Center-EC Cancer Center, Eau Claire
a 25 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Langlade Hospital and Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
a 28 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Minnesota Oncology Hematology, P.A., Hudson

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07227415

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ThedaCare Regional Cancer Center, Appleton

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Froedtert and The Medical College of Wisconsin, Milwaukee

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07188896

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

ThedaCare Regional Cancer Center, Appleton
Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
a 30 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06661720

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06582017

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Wisconsin (Carbone Cancer Center), Madison

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 6. 2026 · NCT06026410

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Clinic-Chippewa Center, Chippewa Falls
Marshfield Medical Center-EC Cancer Center, Eau Claire
a 28 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT04510597

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.